Loading…
The Archive · 3 posts
Innovating skin health! 🌟 SkinBioTherapeutics PLC (SBTX) leads the way in skin care sciences with groundbreaking biotechnologies. 🧬
Showing 2 of 3 posts
SkinBioTherapeutics' FY25: 284% revenue surge driven by first Croda royalties and Superdrug retail launch.
JoshuaDecember 5, 2025
SkinBioTherapeutics quadruples FY25 revenue to £4.5m-£4.8m, nears EBITDA profitability, and prepares for transformative Superdrug Autumn launch.
JoshuaAugust 14, 2025
SkinBioTherapeutics restates FY25 results after board investigation finds fabricated revenue. Cash intact but governance overhaul needed. Key investor takeaways.
June 8, 2026